# Cylene Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cylene-pharmaceuticals

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.cylenepharma.com
- Total disclosed funding: $89M
- Latest round: Series C (Sep 24, 2010)
- Investors on record: 14

## About

Founded in 2001, Cylene Pharmaceuticals Inc., is based in San Diego, US and is a biotech pharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs that target nucleolus and kill cancer cells.

## Funding rounds

- Series C, Sep 24, 2010, $12M — BioVentures Investors, Sanderling Ventures, HBM Partners, Novartis Venture Fund, Lilly Ventures, Mitsui Global Investment, 5Y Capital
- Series C, Jan 23, 2007, $44M — BioVentures Investors, Sanderling Ventures, HBM Partners, Novartis Venture Fund, Lilly Ventures, Mitsui Global Investment, Research Corporation Technologies, Celgene
- Series B, May 25, 2005, $26M — BioVentures Investors, Novartis Venture Fund, Mesa Verde Venture Partners, Mitsui Global Investment, Research Corporation Technologies, Coastview Capital, 5Y Capital, William Harris Investors, Viterbi Group, Lakeview Capital Management
- Series A, Jun 1, 2001, $6.5M — Sanderling Ventures, Novartis Venture Fund, Mesa Verde Venture Partners, Research Corporation Technologies

## Investors

- Sanderling Ventures (https://capitalatlas.ai/funds/sanderling-ventures) — Series A, Series C
- Novartis Venture Fund (https://capitalatlas.ai/funds/novartis-venture-fund) — Series A, Series B, Series C
- Mesa Verde Venture Partners (https://capitalatlas.ai/funds/mesa-verde-venture-partners) — Series A, Series B
- Research Corporation Technologies (https://capitalatlas.ai/funds/research-corporation-technologies) — Series A, Series B, Series C
- BioVentures Investors (https://capitalatlas.ai/funds/bioventures-investors) — Series B, Series C
- Mitsui Global Investment (https://capitalatlas.ai/funds/mitsui-global-investment) — Series B, Series C
- Coastview Capital (https://capitalatlas.ai/funds/coastview-capital) — Series B
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Series B, Series C
- William Harris Investors — Series B
- Viterbi Group (https://capitalatlas.ai/funds/viterbi-group) — Series B
- Lakeview Capital Management — Series B
- HBM Partners (https://capitalatlas.ai/funds/hbm-partners) — Series C
- Lilly Ventures (https://capitalatlas.ai/funds/lilly-ventures) — Series C
- Celgene — Series C